Abstract
The present meta-analysis found no significant difference between hybrid coronary revascularization (HCR) and bypass surgery (CABG) regarding intermediate-term major adverse cardiac and cerebrovascular events. HCR is feasible, historically with higher revascularization rates but less perioperative morbidity With a comparable frequency of repeat revascularization between current-generation drug-eluting stents and CABG, future trials of HCR are considering multi-vessel PCI as the new comparator.
Original language | English |
---|---|
Pages (from-to) | 213-214 |
Number of pages | 2 |
Journal | Catheterization and Cardiovascular Interventions |
Volume | 91 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1 2018 |
Bibliographical note
Publisher Copyright:© 2018 Wiley Periodicals, Inc.
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Cardiology and Cardiovascular Medicine